12:00 AM
Sep 13, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Undisclosed: Began Phase I testing

Novartis Pharma AG, Basel, Switzerland
Product: Undisclosed
Business: Undisclosed
Therapeutic category: Undisclosed
Target: Undisclosed
Description: Solid...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >